KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $181.0 million.

  • Bausch Health Companies' Net Income towards Common Stockholders rose 296.74% to $181.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.0 million, marking a year-over-year increase of 247.93%. This contributed to the annual value of -$72.0 million for FY2024, which is 88.22% up from last year.
  • Per Bausch Health Companies' latest filing, its Net Income towards Common Stockholders stood at $181.0 million for Q3 2025, which was up 41.41% from $128.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Net Income towards Common Stockholders ranged from a high of $403.0 million in Q3 2022 and a low of -$680.0 million during Q1 2021.
  • Its 3-year average for Net Income towards Common Stockholders is -$41.8 million, with a median of -$47.0 million in 2023.
  • In the last 5 years, Bausch Health Companies' Net Income towards Common Stockholders slumped by 669.44% in 2022 and then soared by 12,900.00% in 2025.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Net Income towards Common Stockholders stood at $72.0 million in 2021, then slumped by 669.44% to -$410.0 million in 2022, then surged by 88.54% to -$47.0 million in 2023, then spiked by 308.51% to $98.0 million in 2024, then skyrocketed by 296.74% to $181.0 million in 2025.
  • Its Net Income towards Common Stockholders stands at $181.0 million for Q3 2025, versus $128.0 million for Q2 2025 and -$86.0 million for Q1 2025.